Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kones

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Drug Design, Development and Therapy|January 27, 2011
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveRichard Kones
Vascular Health and Risk Management|August 24, 2010
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparitiesRichard Kones
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|August 13, 2010
Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutritionRichard Kones
Therapeutic Advances in Cardiovascular Disease|February 8, 2013
Reducing residual risk: modern pharmacochemistry meets old-fashioned lifestyle and adherence improvementRichard Kones
Vascular Health and Risk Management|November 1, 2013
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomesRichard Kones
Vascular Health and Risk Management|September 23, 2010
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularizationRichard Kones
Therapeutic Advances in Cardiovascular Disease|December 25, 2010
Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular preventionRichard Kones
Drug Design, Development and Therapy|July 28, 2011
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive surveyRichard Kones
Therapeutic Advances in Cardiovascular Disease|May 23, 2009
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular diseaseRichard Kones
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 22, 2010
Low-fat versus low-carbohydrate diets, weight loss, vascular health, and prevention of coronary artery disease: the evidence, the reality, the challenge, and the hopeRichard Kones
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|January 27, 2011
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveRichard Kones
Vascular Health and Risk Management|August 24, 2010
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparitiesRichard Kones
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|August 13, 2010
Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutritionRichard Kones
Therapeutic Advances in Cardiovascular Disease|February 8, 2013
Reducing residual risk: modern pharmacochemistry meets old-fashioned lifestyle and adherence improvementRichard Kones
Vascular Health and Risk Management|November 1, 2013
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomesRichard Kones
Vascular Health and Risk Management|September 23, 2010
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularizationRichard Kones
Therapeutic Advances in Cardiovascular Disease|December 25, 2010
Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular preventionRichard Kones
Drug Design, Development and Therapy|July 28, 2011
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive surveyRichard Kones
Therapeutic Advances in Cardiovascular Disease|May 23, 2009
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular diseaseRichard Kones
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 22, 2010
Low-fat versus low-carbohydrate diets, weight loss, vascular health, and prevention of coronary artery disease: the evidence, the reality, the challenge, and the hopeRichard Kones
Pageof 4